GLI1 expression
|
NSCLC
|
GLI1 expression
|
NSCLC
|
erlotinib Sensitive: C3 – Early Trials
|
erlotinib Sensitive: C3 – Early Trials
|
GLI1 expression
|
Pancreatic Ductal Adenocarcinoma
|
GLI1 expression
|
Pancreatic Ductal Adenocarcinoma
|
sonidegib Sensitive: D – Preclinical
|
sonidegib Sensitive: D – Preclinical
|